Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids

Fig. 3

Percent change from baseline to Day 29 in a siVaw and b siRaw. Images show one representative patient’s data for siVaw (mL/L) and siRaw (kPa·s) percent change from baseline to Day 29 at TLC. Green coloring represents a an increase in airways volume and b a decrease in airway resistance. Orange coloring indicates the converse. BGF budesonide/glycopyrrolate/formoterol fumarate, GFF glycopyrrolate/formoterol fumarate, siRaw specific image-based airway resistance, siVaw specific image-based airway volume, TLC total lung capacity

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us